Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Revenue: ¥8,196 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600436 Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHSE:600436
84 GF Score
Price ¥122.76
GF Value ¥163.48
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Zhangzhou Pientzehuang Pharmaceutical Co Revenue?

Zhangzhou Pientzehuang Pharmaceutical Co SHSE:600436 -0.11% 84 Revenue is ¥8,196 Mil as of Jun. 2026. GuruFocus rates SHSE:600436 with a GF Score™ of 84/100 and a GF Value™ of ¥163.48 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Zhangzhou Pientzehuang Pharmaceutical Co's revenue for the three months ended in Jun. 2026 was ¥1,832 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ¥8,196 Mil. Zhangzhou Pientzehuang Pharmaceutical Co's Revenue per Share for the three months ended in Jun. 2026 was ¥3.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ¥13.58.

Warning Sign:

Zhangzhou Pientzehuang Pharmaceutical Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Zhangzhou Pientzehuang Pharmaceutical Co was -22.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 18.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Zhangzhou Pientzehuang Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 44.20% per year. The lowest was -2.30% per year. And the median was 16.25% per year.


Zhangzhou Pientzehuang Pharmaceutical Co  (SHSE:600436) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Zhangzhou Pientzehuang Pharmaceutical Co Revenue Related Terms


Zhangzhou Pientzehuang Pharmaceutical Co Revenue Historical Data

* Premium members only.

The historical data trend for Zhangzhou Pientzehuang Pharmaceutical Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhangzhou Pientzehuang Pharmaceutical Co Revenue Chart

Zhangzhou Pientzehuang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,021.55 8,694.00 10,058.50 10,787.86 9,001.41

Zhangzhou Pientzehuang Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,237.01 2,063.83 1,559.05 2,741.28 1,831.56

SHSE:600436 vs LLY, JNJ, ABBV: Revenue Comparison

For the Drug Manufacturers - General subindustry, Zhangzhou Pientzehuang Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhangzhou Pientzehuang Pharmaceutical Co Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhangzhou Pientzehuang Pharmaceutical Co's Revenue distribution charts can be found below:

* The bar in red indicates where Zhangzhou Pientzehuang Pharmaceutical Co's Revenue falls into.


SHSE:600436
84GF Score
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHSE:600436
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhangzhou Pientzehuang Pharmaceutical Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥8,196 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of ¥8,196 Mil mean?
Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) has a Revenue of ¥8,196 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Zhangzhou Pientzehuang Pharmaceutical Co and its competitors.
Is Zhangzhou Pientzehuang Pharmaceutical Co's Revenue too high?
Zhangzhou Pientzehuang Pharmaceutical Co's current Revenue is ¥8,196 Mil. Overall, Zhangzhou Pientzehuang Pharmaceutical Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhangzhou Pientzehuang Pharmaceutical Co's Revenue compare to LLY and JNJ?
Zhangzhou Pientzehuang Pharmaceutical Co's Revenue of ¥8,196 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Zhangzhou Pientzehuang Pharmaceutical Co and its competitors. Zhangzhou Pientzehuang Pharmaceutical Co's current Revenue is ¥8,196 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhangzhou Pientzehuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥163.48, compared to a current price of ¥122.76 — trading 24.9% below its estimated fair value. The current Revenue is ¥8,196 Mil. Zhangzhou Pientzehuang Pharmaceutical Co's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436), the current Revenue is ¥8,196 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Overvalued in 2026?

Based on GuruFocus' analysis, Zhangzhou Pientzehuang Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥122.76 is trading 24.9% below its estimated GF Value™ of ¥163.48. GuruFocus considers Zhangzhou Pientzehuang Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600436:

  • Revenue: ¥8,196 Mil
  • GF Value™: ¥163.48 vs. price of ¥122.76 (24.9% below fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600436 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhangzhou Pientzehuang Pharmaceutical Co Business Description

Address No. 1, Hupo Road, Xiangcheng District, Fujian Province, Zhangzhou, CHN, 363000
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include tablets, hard capsules, granules, pills (water pills, honey pills), syrups, tinctures (including external use), ointments, lozenges, decoctions, Chinese herbal medicine slices (including direct oral slices) (clean preparation); production of candy products (candy), health food products; and production of beverages (solid beverages).
84GF Score

Get the complete analysis for SHSE:600436

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥122.76
Price
¥163.48
GF Value